RESUMO
BACKGROUND: Our ability to guide cells in biomaterials for in vivo bone repair is limited and requires novel strategies. Short-interfering RNA (siRNA) allows the regulation of multiple cellular pathways. Core binding factor alpha 1 (Cbfa1) and hypoxia-inducible factor 1 (HIF-1) pathways can be modulated to direct bone formation via siRNA against guanine nucleotide-binding protein alpha-stimulating activity polypeptide 1 (siGNAS1) and prolyl hydroxylase domain-containing protein 2 (siPHD2), respectively. QUESTIONS/PURPOSES: We determined whether the administration of siGNAS1 and siPHD2 in mesenchymal stem cells (MSCs) promotes osteogenic phenotype, the dose-dependent effects of siGNAS1 on MSC differentiation to osteogenic phenotype, and whether the two siRNAs promote bone formation in vivo. METHODS: siRNAs were administered to MSCs at Day 0, and protein expression of bone-specific markers was assessed at Days 1, 2, and 4 (n = 3/group/time point). In an in vivo model using seven sheep, chambers containing silk fibroin-chitosan (SFCS) scaffolds with siRNA were implanted over the periosteum and harvested at Days 7, 21, 36, and 70 (n = 4/group/time point, except at Day 70 [n = 2]) to assess bone formation. RESULTS: siGNAS1 promoted collagen I and osteopontin expression, whereas siPHD2 had no effect in vitro. Dose-dependent effects of siGNAS1 on ALP expression were maximal at Day 1 for 10 µg/mL and Day 4 for 100 µg/mL. In vivo, by Day 70, mean bone volume increased compared to Day 7 for siGNAS1-SFCS (47.8 versus 1.8 mg/mL) and siPHD2-SFCS (61.3 versus 1.5 mg/mL). CONCLUSIONS: Both siPHD2 and siGNAS1 support bone regeneration in vivo, whereas only siGNAS1 regulates bone phenotype in MSCs in vitro.
Assuntos
Regeneração Óssea/genética , Subunidades alfa Gs de Proteínas de Ligação ao GTP/genética , Terapia Genética/métodos , Células-Tronco Mesenquimais/enzimologia , Periósteo/enzimologia , Pró-Colágeno-Prolina Dioxigenase/genética , Interferência de RNA , RNA Interferente Pequeno/metabolismo , Fosfatase Alcalina/metabolismo , Animais , Biomarcadores/metabolismo , Densidade Óssea , Diferenciação Celular , Proliferação de Células , Células Cultivadas , Cromograninas , Colágeno Tipo I/metabolismo , Subunidades alfa Gs de Proteínas de Ligação ao GTP/metabolismo , Regulação da Expressão Gênica , Genótipo , Humanos , Prolina Dioxigenases do Fator Induzível por Hipóxia , Laminina/genética , Laminina/metabolismo , Modelos Animais , Osteopontina/metabolismo , Periósteo/diagnóstico por imagem , Periósteo/patologia , Fenótipo , Pró-Colágeno-Prolina Dioxigenase/metabolismo , RNA Interferente Pequeno/administração & dosagem , Ovinos , Fatores de Tempo , Alicerces Teciduais , Transfecção , Microtomografia por Raio-XRESUMO
We report on the in vitro use of Ca(2+)/P(i) supplementation as a bio-instructive medium to drive human periosteum-derived cells (hPDCs) toward osteogenic differentiation on three-dimensional (3D) porous Ti6Al4V scaffolds. Through a multilevel factorial analysis, we have systematically investigated the biological effect and interactions of Ca(2+) or P(i) supplementation in three selected media preparations (i.e., basic growth medium, osteogenic medium [OM], and osteogenic medium without ß-glycerophosphate [OM(-)]) and have identified specific conditions which induce proliferation and significant osteogenic differentiation of two-dimensional (2D) hPDC cultures. These findings were translated from 2D to 3D cultures conditions to instruct hPDCs to populate porous Ti6Al4V scaffolds and to differentiate into the osteoblast lineage with collagenous matrix production and subsequent matrix mineralization on the 3D structures. These osteogenic hybrids may potentially serve as a clinically relevant customizable bone reparative unit, providing a biomimetic template to more effectively mediate in vivo bone regeneration.
Assuntos
Materiais Biocompatíveis/farmacologia , Biomimética/métodos , Cálcio/farmacologia , Análise Multinível , Osteogênese/efeitos dos fármacos , Fosfatos/farmacologia , Engenharia Tecidual/métodos , Adolescente , Fosfatase Alcalina/metabolismo , Ligas , Calcificação Fisiológica/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Forma Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Matriz Extracelular/efeitos dos fármacos , Matriz Extracelular/metabolismo , Análise Fatorial , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Osteogênese/genética , Periósteo/citologia , Periósteo/efeitos dos fármacos , Periósteo/enzimologia , Porosidade/efeitos dos fármacos , Alicerces Teciduais/química , Titânio/farmacologiaRESUMO
Human cultured periosteal sheets, which are developed from small excised periosteum tissue segments (PTSs) in culture dishes by simple expansion culture, have been applied as a promising autologous osteogenic grafting material for periodontal regenerative therapy. However, the weak initial adhesion of PTSs to dish surfaces often hampers cellular outgrowth and limits the number of preparations. To correct this weakness and still avoid the use of animal-derived adhesion biomolecules, we have developed a novel, biodegradable, porous poly(L-lactic acid) (pPLLA) membrane. Freshly excised PTSs bound well to the highly porous pPLLA membrane, possibly due to the presence of semihemispheric 20-30 µm diameter openings on the upper surface. Global gene expression analysis demonstrated that periosteal sheets cultured on pPLLA membranes upregulated expression of many adhesion molecules. Osteogenic induction stimulated the production of proteoglycans by these cells and concomitantly enhanced their expansion and penetration into the deep pore regions of the membrane in parallel with the progression of in vitro mineralization. These findings suggest that our pPLLA membranes not only facilitate initial adhesion, primarily mediated by adsorbed proteins, but also enhance biological adhesion by inducing endogenous adhesion molecules in periosteal sheet cultures. Therefore, the efficacy of periosteal sheets in therapy should be greatly enhanced by using this new pPLLA membrane.
Assuntos
Moléculas de Adesão Celular/farmacologia , Ácido Láctico/farmacologia , Periósteo/citologia , Periósteo/efeitos dos fármacos , Polímeros/farmacologia , Alicerces Teciduais/química , Fosfatase Alcalina/metabolismo , Adesão Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Forma Celular/efeitos dos fármacos , Células Cultivadas , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Microscopia Eletrônica de Varredura , Periósteo/enzimologia , Poliésteres , Porosidade/efeitos dos fármacos , Proteoglicanas/genética , Proteoglicanas/metabolismo , Fatores de TempoRESUMO
Transplantable cell sheets containing osteoblasts were fabricated from periostea on temperature-responsive culture dishes. This study demonstrated the time-course of bone regeneration in living small animals. This continuous observation of bone regeneration was achieved by micro-computed tomography (µCT), which assessed the osteogenic capability of periosteal cells without biodegradable scaffolds. Real-time bone regeneration was non-invasively monitored in a rat calvarial bone defect model, using µCT. Three-dimensional (3D) images obtained over time by µCT clearly showed that two different bone regeneration modes, specific to the control and experimental groups, were observed. In the control group, bone was regenerated only from the periphery of the defect edges. In the experimental group, bone regeneration was observed in several small regions within the central portions of the defects that were covered by the transplanted cell sheets. However, bone regeneration observed after periosteal cell sheet transplantation was limited. The results of ALP staining and the time-course observations concluded that periosteal cell sheets contained a small fraction of cells that could differentiate osteoblasts. Fibroblasts in transplanted cell sheets or from around subcutaneous tissues suppressed bone regeneration. The periosteal cell sheets had a capability to produce ectopic regenerated bones. Therefore, to increase the content of osteogenic cells in harvested cell sheets, the enrichment of cells that could produce osteoblasts was expected by the modification of the initial cell preparation and the culture conditions. With further possible improvements, scaffold-free periosteal cell sheet fabricated on temperature-responsive culture dishes will be a valuable method for inducing and accelerating bone regeneration.
Assuntos
Regeneração Óssea/fisiologia , Imageamento Tridimensional/métodos , Periósteo/transplante , Crânio/diagnóstico por imagem , Temperatura , Técnicas de Cultura de Tecidos/métodos , Microtomografia por Raio-X/métodos , Fosfatase Alcalina/metabolismo , Animais , Calcificação Fisiológica/fisiologia , Periósteo/citologia , Periósteo/enzimologia , Ratos , Crânio/fisiologia , Coloração e RotulagemRESUMO
Despite the important physiological role of periosteum in the pathogenesis and treatment of osteoporosis, little is known about the structural and cellular characteristics of periosteum in osteoporosis. To study the structural and cellular differences in both diaphyseal and metaphyseal periosteum of osteoporotic rats, samples from the right femur of osteoporotic and normal female Lewis rats were collected and tissue sections were stained with hematoxylin and eosin, antibodies or staining kit against tartrate resistant acid phosphatase (TRAP), alkaline phosphatase (ALP), vascular endothelial growth factor (VEGF), von Willebrand (vWF), tyrosine hydroxylase (TH) and calcitonin gene-related peptide (CGRP). The results showed that the osteoporotic rats had much thicker and more cellular cambial layer of metaphyseal periosteum compared with other periosteal areas and normal rats (P < 0.001). The number of TRAP(+) osteoclasts in bone resorption pits, VEGF(+) cells and the degree of vascularization were found to be greater in the cambial layer of metaphyseal periosteum of osteoporotic rats (P < 0.05), while no significant difference was detected in the number of ALP(+) cells between the two groups. Sympathetic nerve fibers identified by TH staining were predominantly located in the cambial layer of metaphyseal periosteum of osteoporotic rats. No obvious difference in the expression of CGRP between the two groups was found. In conclusion, periosteum may play an important role in the cortical bone resorption in osteoporotic rats and this pathological process may be regulated by the sympathetic nervous system.
Assuntos
Diáfises/patologia , Osteoporose/patologia , Periósteo/patologia , Fosfatase Ácida/metabolismo , Fosfatase Alcalina/metabolismo , Animais , Vasos Sanguíneos/metabolismo , Vasos Sanguíneos/patologia , Peptídeo Relacionado com Gene de Calcitonina/metabolismo , Diáfises/irrigação sanguínea , Diáfises/enzimologia , Feminino , Imuno-Histoquímica , Isoenzimas/metabolismo , Osteoclastos/enzimologia , Osteoclastos/patologia , Osteoporose/enzimologia , Periósteo/irrigação sanguínea , Periósteo/enzimologia , Periósteo/inervação , Ratos , Ratos Endogâmicos Lew , Coloração e Rotulagem , Fosfatase Ácida Resistente a Tartarato , Tirosina 3-Mono-Oxigenase/metabolismo , Fator A de Crescimento do Endotélio Vascular/metabolismo , Fator de von Willebrand/metabolismoRESUMO
Our recent clinical studies have demonstrated that autologous implantation of human cultured periosteal (hCP) sheets in combination with porous hydroxylapatite (HAp) particles at the site of periodontal bone defects strikingly facilitates tissue regeneration. To better understand how the hCP sheet functions at the implantation site, we have now examined its biochemical and morphological characteristics in vitro and its ectopic osteoinductivity in nude mice. Cultured human periosteal tissue segments produced periosteal cells that migrated out from the central region within 4-8 days and grew more rapidly with longer culture times. Alkaline phosphatase activity increased in parallel with actual osteoblastic induction. Cytokine array assays demonstrated that osteoblastic induction downregulated IL-6 and thrombopoietin, but upregulated IL-8, IL-13, IGF-I and IGFBP-2 in hCP sheets. When differentiated hCP sheets were implanted alone, areas of osteoid and mineralized tissue were formed within 2 weeks, but non-induced, immature hCP sheets did not produce much mineralization. These findings suggest that mature hCP sheets potentially function not only as seeds of ectopic bone formation without the need of synthetic tissue scaffolds, but also as living drug-delivery systems, to influence cells near implantation sites by producing several important cytokines. These two major characteristics indicate that a mature hCP sheet is a promising osteoinductive biomaterial, even without conventional scaffolds for periodontal regenerative therapy.
Assuntos
Modelos Animais , Osteogênese , Periósteo/citologia , Adulto , Fosfatase Alcalina/metabolismo , Animais , Cálcio/metabolismo , Proliferação de Células , Forma Celular , Células Cultivadas , Citocinas/metabolismo , Feminino , Humanos , Masculino , Camundongos , Camundongos Nus , Parafina , Periósteo/enzimologia , Periósteo/metabolismo , Proteômica , Medicina Regenerativa , Fatores de TempoRESUMO
BACKGROUND: Assessment of bone formation activity is an important component of pharmacologic efficacy and toxicity evaluations for compounds in development for osteoporosis therapies. Antemortem biomarkers of bone formation and remodeling in rodents are uncommon. While the periosteal alkaline phosphatase (ALP) assay is a postmortem and laborious means of testing bone-building activity, the semiautomated ALP isoenzyme assay is an antemortem assay that is performed on an automated chemistry analyzer after 2 simple dilutions of the initial serum sample and a short incubation. OBJECTIVES: The goal of our investigation was to determine if the serum bone ALP (BALP) data obtained from the semiautomated ALP isoenzyme assay had a similar pattern of response when compared with the periosteal ALP (PALP) assay for use in pharmacologic screening in rats. METHODS: Serum and bone tissue samples were obtained from orchidectomized Wistar rats, a model of clinically induced osteoporosis. Subsequent bone formation was initiated via treatment with one of several compounds. In study 1, orchidectomized male rats were given either vehicle, dihydrotestosterone or a testosterone derivative subcutaneously every 4 days for 28 days. In study 2, orchidectomized male rats were given either vehicle or compounds A, B, or C by oral gavage daily for 15 days. Blood and tibias were collected at necropsy. Serum was analyzed for BALP activity using a semiautomated ALP assay. Tibias from the same rats were analyzed for PALP activity. RESULTS: Serum BALP activity paralleled PALP activity within each group when compared with the controls. CONCLUSION: Our data indicate that the semiautomated serum BALP isoenzyme assay may be used as a biomarker of bone-building potential in rat models of osteoporosis. This assay affords many advantages to investigators of musculoskeletal diseases, including the potential to measure multiple data points in a single study.
Assuntos
Fosfatase Alcalina/análise , Fosfatase Alcalina/sangue , Periósteo/enzimologia , Fosfatase Alcalina/metabolismo , Animais , Autoanálise , Automação , Isoenzimas/análise , Isoenzimas/sangue , Isoenzimas/metabolismo , Masculino , Ratos , Ratos WistarRESUMO
OBJECTIVE: To evaluate both the potential for transferring genes to periosteal cells using an adeno-associated virus (AAV) vector and the potential for gene expression after transplantation of those cells to a cartilage defect in vivo. METHODS: Periosteum was obtained from the tibia of 6-week-old rabbits and enzymatically digested. The isolated periosteum derived cells were cultured and the subconfluence cells were infected with a recombinant AAV expressing the LacZ gene (AAV-LacZ). Collagen gel containing the LacZ transferred, periosteum derived cells was transplanted into a full thickness articular cartilage defect in 10 rabbits. RESULTS: Infected cells still growing on the plate continued to express LacZ at least 12 weeks after AAV infection, with the highest percentage of LacZ positive cells reaching 74.4%. The LacZ positive cells were recognized at the transplant sites in 8 out of 10 knees. CONCLUSION: Gene expression in periosteum derived cells was sustained in vitro for at least 12 weeks using the AAV vector, and for 2 weeks ex vivo after transplantation into a cartilage defect.
Assuntos
Adenovírus Humanos/genética , Cartilagem Articular/patologia , Vetores Genéticos/genética , Periósteo/citologia , Transdução Genética , Cicatrização , Animais , Cartilagem Articular/enzimologia , Cartilagem Articular/lesões , Transplante de Células , Células Cultivadas , Marcadores Genéticos , Humanos , Articulações/cirurgia , Óperon Lac/genética , Periósteo/enzimologia , Periósteo/virologia , Coelhos , beta-Galactosidase/metabolismoRESUMO
Tissue engineering using periosteal cells is a promising approach for bioactive bone repair. Of central importance in tissue engineering is the cell-matrix interaction. In the present study we tested in vitro the influence of alpha-tricalcium phosphate (alpha-TCP) particles on the expression of osteogenic markers in rabbit periosteal cells embedded in specially manufactured fibrin beads. After cell isolation from tibial periosteum of New Zealand White rabbits, and following monolayer culture, cells were embedded in alginate-fibrin beads containing 7.5% alpha-TCP particles and, as a control group, in beads without particles. The alginate was extracted immediately after polymerization. The beads were cultivated for at least 53 days. The DNA content, alkaline phosphatase activity, and osteocalcin level were determined. In monolayer culture the number of cells increased 6.5-fold. DNA content increased in both three-dimensional culture groups but was significantly higher in the beads containing alpha-TCP. Alkaline phosphatase activity increased in both groups without significant differences. Osteocalcin content was significantly higher in the beads containing alpha-TCP than it was in those without alpha-TCP. These observations indicate that matrix engineering using inorganic particles in fibrin culture can influence the osteogenic differentiation of mesenchymal cells. The three-dimensional culture system presented here facilitates the preparation of grafts for bone reconstruction.
Assuntos
Osso e Ossos/citologia , Fosfatos de Cálcio , Diferenciação Celular , Matriz Extracelular , Periósteo/citologia , Engenharia Tecidual , Fosfatase Alcalina/metabolismo , Animais , Osso e Ossos/enzimologia , Osso e Ossos/metabolismo , Divisão Celular , Osteocalcina/metabolismo , Periósteo/enzimologia , Periósteo/metabolismo , CoelhosRESUMO
OBJECTIVE: To determine an optimal co-culture ratio of the rabbit periosteal osteoblasts (RPOB) and rabbit renal vascular endothelial cells(RRVEC) without direct contact for future study of bone tissue engineering. METHODS: RPOB and RRVEC in the ratios of 1:0(control group), 2:1(group 1), 1:1(group 2) and 1:2(group 3) were co-cultured by six well plates and cell inserts. Four days later, the proliferation of RPOB and RRVEC were examined through cell count. Differentiated cell function was assessed by alkaline phosphatase (ALP) activity assay and 3H proline incorporation assay. RESULTS: When RPOB and RRVEC were indirectly co-cultured, the proliferation of RPOB and 3H proline incorporation was higher in group 1 than in the other experimental groups and control group (P < 0.05). ALP activity of RPOB was higher in group 1 than in control group and group 3 (P < 0.05), but there was no significant difference between group 1 and group 2 (P > 0.05). CONCLUSION: These results suggest that RPOB and RRVEC co-cultured in a ratio of 2:1 is optimal for future study of bone tissue engineering.
Assuntos
Endotélio Vascular/citologia , Osteoblastos/citologia , Periósteo/citologia , Fosfatase Alcalina/metabolismo , Animais , Técnicas de Cultura de Células/métodos , Osteoblastos/enzimologia , Periósteo/enzimologia , Prolina/metabolismo , Coelhos , Engenharia TecidualRESUMO
The possibility that the nervous system may control bone metabolism has been raised, as neuromediators physiologically conveyed by sympathetic fibers (eg, vasoactive intestinal peptide) influence bone resorption in vitro. In this study, the sympathetic system was inactivated by treating rats with guanethidine (40 mg/kg/day), a sympathetic neurotoxic, for 21 days, after which a wave of osteoclastic resorption was induced along the mandibular buccal cortex. The effects of denervation were assessed 4 days later (corresponding to the peak of resorption in this model). The rats exhibited ptosis soon after starting guanethidine, proving the success of the sympathectomy. This was associated with a significant increase in calcitonin gene-related peptide- (+54%, p < 0.02) and substance P-immunoreactive sensory fibers (+29%,p < 0.02), a known effect of sympathectomy. For the quantitation of the bone parameters, the study zone was divided into a juxta-osseous alkaline phosphatase-positive osteogenic compartment and a nonosteogenic compartment. In the osteogenic compartment, the resorption surface was reduced by 56% (p < 0.001) in the treated animals, together with a fall in the number of osteoclasts (-25%,p < 0.05) and impaired osteoclast access to the bone surface. Tartrate-resistant acid phosphatase-positive (TRAP+) mononuclear preosteoclasts were found only in this compartment; they were reduced by 43% (p < 0.05) by the sympathectomy. No change in non-specific esterase (NSE)+ osteoclast precursors was found. In the nonosteogenic compartment, vasodilation was the only effect of sympathectomy (+80%,p < 0.05); in particular, the number of NSE+ cells was not modified. Our results indicate that: (1) interactions of NSE+ precursors with osteogenic cells are required for their differentiation into TRAP+ preosteoclasts; (2) the sympathetic nervous system is not involved in osteoclast precursor recruitment; but (3) has a significant effect on resorption by inhibiting preosteoclast differentiation and disturbing osteoclast activation. These data suggest that depletion of sympathetic mediators may disturb osteogenic cell-mediated osteoclast differentiation.
Assuntos
Reabsorção Óssea/metabolismo , Reabsorção Óssea/fisiopatologia , Periósteo/inervação , Periósteo/metabolismo , Simpatectomia Química , Sistema Nervoso Simpático/fisiologia , Fosfatase Alcalina/análise , Fosfatase Alcalina/metabolismo , Animais , Peptídeo Relacionado com Gene de Calcitonina/metabolismo , Peptídeo Relacionado com Gene de Calcitonina/fisiologia , Polpa Dentária/inervação , Guanetidina , Masculino , Mandíbula/enzimologia , Mandíbula/inervação , Mandíbula/metabolismo , Osteoclastos/citologia , Periósteo/citologia , Periósteo/enzimologia , Ratos , Ratos Wistar , Substância P/metabolismo , Substância P/fisiologiaRESUMO
Recent data suggest that gelatinase A (matrix metalloproteinase-2, MMP-2) plays an important role in the degradation of collagen of soft connective tissues. In an attempt to investigate its participation in more detail we assessed the digestion of collagen in cultured rabbit periosteal explants and compared this with the level of active MMP-2 and collagenases. The data demonstrated that both collagen degradation and MMP activity increased with time. Conditioned medium obtained from explants cultured for 72 h showed that the level of active MMP-2 correlated with collagen degradation (r = 0.80, d.f. = 23, P < 0.0001). Such a relationship was not found with collagenase activity (r = -0.08, d.f. = 21, NS). The possible involvement of MMP-2 in collagen degradation was investigated further by incubating explants with selective gelatinase inhibitors (CT1166, CT1399 and CT1746). In the presence of these compounds breakdown of collagen was almost completely abolished (approximately 80%). Finally we assessed whether periosteal fibroblasts had the capacity to degrade collagen type I that conferred resistance to collagenase activity. Breakdown of this collagen did not differ from degradation of normal collagen. Taken together, our data provide support for the view that MMP-2 plays a crucial role in collagen degradation of soft connective tissue.
Assuntos
Colágeno/metabolismo , Colagenases/metabolismo , Tecido Conjuntivo/metabolismo , Metaloproteinase 2 da Matriz/metabolismo , Animais , Tecido Conjuntivo/enzimologia , Técnicas de Cultura , Interpretação Estatística de Dados , Hidroxiprolina/metabolismo , Imuno-Histoquímica , Metaloproteinase 1 da Matriz/metabolismo , Metaloproteinase 13 da Matriz , Metaloproteinase 8 da Matriz/metabolismo , Metaloproteinases da Matriz/metabolismo , Periósteo/enzimologia , Coelhos , Crânio/enzimologiaRESUMO
Recent data suggests that induction of prostaglandin endoperoxide H synthase-2 (PGHS-2) is critical for the anabolic response of lamellar bone elicited by mechanical strain in vivo. The aim of the present study was to localise PGHS-1 and PGHS-2 in rat tibiae following four-point bending in vivo. Right tibiae of 19 adult female rats were subjected to 300 cycles of bending or sham loading at 2.0 Hz with an applied load of 65 N. At 0, 6, and 24 hr postloading, rats were anaesthetised and perfused with Bouin's fixative. Left and right tibiae were dissected, postfixed for 4 hr at 4 degrees C, decalcified in EDTA, and embedded in paraffin. Serial 5 pM sections were stained for PGHS-1 and PGHS-2 using standard immunoperoxidase procedures. For the first time, immunoreactivity for both PGHS-1 and PGHS-2 was localised in bone cells in situ, in the rat tibia. PGHS-1 was distributed widely in all tibiae, while PGHS-2 showed sparse localisation. At the endocortical surfaces (EcS), osteoblasts, lining cells, and osteocytes close to the surface reacted strongly for PGHS-1, as did intracortical osteocytes. At the periosteal surface (PsS), osteoblasts and cells of the osteogenic region were immunopositive. Immediately after loading, the numerical density (n.mm(-2)) of osteocytes labeled with PGHS-1 was significantly greater in loaded tibiae compared to controls. This increase was not seen after sham loading. At 6 and 24 hr postloading, this difference was no longer evident. Staining for PGHS-2 was sparse compared to PGHS-1. Light to moderate reactivity was observed in osteocytes and canaliculae, but the numerical density of labeled cells was significantly less than that for PGHS-1. Moderate staining was seen in lining cells and osteoblasts at the EcS and PsS of some tibiae. Osteoclasts at the PsS reacted strongly for both PGHS-1 and PGHS-2. There was a similar load-related increase in the density of PGHS-2-labeled osteocytes 0 hr postloading. The labeled osteocyte density had decreased at 6 hr, but remained significantly greater in loaded bones. These results show that both forms of PGHS can be localised in bone cells, with PGHS-1 expressed to a greater extent than PGHS-2. The data also suggest that both PGHS-1 and PGHS-2 may play important roles in the early response of bone to mechanical loading in vivo.
Assuntos
Isoenzimas/metabolismo , Prostaglandina-Endoperóxido Sintases/metabolismo , Tíbia/enzimologia , Suporte de Carga/fisiologia , Adaptação Fisiológica , Animais , Contagem de Células , Ciclo-Oxigenase 1 , Ciclo-Oxigenase 2 , Feminino , Técnicas Imunoenzimáticas , Proteínas de Membrana , Osteoblastos/citologia , Osteoblastos/enzimologia , Osteoclastos/citologia , Osteoclastos/enzimologia , Periósteo/citologia , Periósteo/enzimologia , Ratos , Ratos Sprague-Dawley , Tíbia/fisiologiaRESUMO
Rabbit bone marrow- and periosteum-derived cells were cultured in medium containing dexamethasone, bone morphogenetic protein-2 (BMP2) or both. The response of bone marrow-derived cells, measured as alkaline phosphatase expression, depended on the stage of growth. In subconfluent cultures, BMP2 had a greater effect than dexamethasone and treatment with both further increased enzyme activity. In confluent cultures, the effect of dexamethasone was greater than that of BMP2 and, when used together, they had an additive effect. The mineral deposition observed in these cultures did not have the typical structure of bone nodules. For periosteum-derived cells, dexamethasone did not increase the expression of alkaline phosphatase, while BMP2 did; treatment with both was less effective than treatment with BMP2 alone. Typical bone nodules were observed in cultures of periosteum-derived cells treated with dexamethasone and BMP2. These findings indicate that either osteoprogenitor cells from these two sources are intrinsically different or else non-progenitor cells in the preparations directly or indirectly affect the responsiveness to osteo-inductive agents.
Assuntos
Células da Medula Óssea/efeitos dos fármacos , Proteínas Morfogenéticas Ósseas/farmacologia , Dexametasona/farmacologia , Osteogênese/efeitos dos fármacos , Periósteo/citologia , Periósteo/efeitos dos fármacos , Fator de Crescimento Transformador beta , Fosfatase Alcalina/análise , Animais , Células da Medula Óssea/fisiologia , Proteína Morfogenética Óssea 2 , Células Cultivadas/efeitos dos fármacos , Meios de Cultura/química , Osteogênese/fisiologia , Periósteo/enzimologia , Periósteo/crescimento & desenvolvimento , Coelhos , Células-Tronco/efeitos dos fármacosRESUMO
Estrogen plays a major role in bone mineral homeostasis, maintaining a balance between bone formation and bone resorption not only in women but also in men. Extraglandular aromatization of circulating androgen is the major source of estrogen in post-menopausal women and men. In order to assess the capacity of bone cells as a local source of estrogen, osteoblast-like cells (OLCs) were obtained from human fetal bone in mid-trimester by the explant method and by mechanical disaggregation. The integrity of OLCs was confirmed by their ability to produce alkaline phosphatase and osteocalcin in response to vitamin D3 and also by their ability to deposit mineral. Aromatase activity was assessed by the formation of estrone from [1,2,6,7-3H]androstenedione and by the release of tritium from [1beta-3H]androstenedione into [3H]water. Formation of estrone was confirmed by thin layer chromatography (TLC) in OLCs stimulated with dexamethasone (DEX) + oncostatin M. The aromatase activity was 10 x higher in non-passaged OLCs than in passaged cells in the presence or absence of the stimulants (DEX + IL-1beta). The apparent Km and Vmax estimated by the release of [3H]water was 5.8+/-0.6 nM and 10.8+/-1.4 pmol/mg per 6 h in the presence of DEX + IL-1beta. The effects of several stimulants on aromatase activity in OLCs were examined: serum, IL-1beta, TNFalpha and type I cytokines stimulated activity in the presence of DEX, while PMA and PMA + dibutyryl cAMP did not. To confirm the expression of aromatase in OLCs, cells prepared from periosteal membranes were also examined: These cells in culture possessed aromatase activity corresponding to OLCs prepared from bone specimens. Moreover, the fresh periosteum expressed aromatase at higher levels than that of metaphyseal specimens. The aromatase gene employs several different promoters (I.1, 1.2, I.3, I.4, I.5, I.6, 2a, 1f and PII) and the usage of these promoters is known to be controlled in a tissue-specific fashion. Accordingly, promoter usage in OLCs and fetal long bone (tibia) tissue was examined using the 5' rapid amplification of cDNA ends (RACE) technique. The major promoter used was I.4, not only in stimulated and non-stimulated OLCs, but also in fetal tibia. Some minor transcripts were also found: 1f (brain-specific promoter), PII and I.6 in OLCs stimulated by DEX + IL-1beta, and PII and I.3 in OLCs stimulated by DEX + serum. Fetal tibia also expressed I.3 (15%) and I.6 (10%). Thus, regulation and promoter usage in OLCs was quite different from other tissues known as estrogen sources including adipose tissue, ovary and placenta. These results suggest that bone is an extraglandular source of local estrogen which plays an important role in bone mineral metabolism through autocrine and paracrine actions.
Assuntos
Aromatase/genética , Regulação Enzimológica da Expressão Gênica/genética , Osteoblastos/enzimologia , Regiões Promotoras Genéticas/genética , Fosfatase Alcalina/análise , Calcitriol/farmacologia , Divisão Celular , Células Cultivadas , Meios de Cultivo Condicionados , Citocinas/farmacologia , Dexametasona/farmacologia , Feto , Glucocorticoides/farmacologia , Humanos , Cinética , Minerais/análise , Osteoblastos/citologia , Osteocalcina/análise , Periósteo/citologia , Periósteo/enzimologiaRESUMO
Prostaglandin E stimulates bone formation in humans and animals, and increases intracellular cAMP in osteoblastic cells. We found that cAMP inhibits apoptosis in osteoblastic cells, and examined the mechanism of this effect. We report that the cAMP elevating agent, forskolin, increases cell number in the rat periosteal cell line (RP-11), by suppressing apoptosis in a cell type-specific manner. In RP-11, forskolin transiently up-regulates extracellular signal-regulated kinase activity, a known suppressor of apoptosis. PD98059, a selective inhibitor of the extracellular signal-regulated kinase pathway, only partially reverses the antiapoptotic effect of forskolin, which suggests an additional mechanism for cAMP action. We found that forskolin stimulates cytosolic sphingosine kinase (SPK) activity in these cells; in two other osteoblastic cell lines, however, forskolin does not suppress apoptosis. In contrast to the partial opposing effect of PD98059 to forskolin action, N, N-dimethylsphingosine, a specific inhibitor of SPK, completely reverses the antiapoptotic effect of forskolin, and has no effect on apoptosis in the absence of forskolin. These findings show for the first time that cAMP activates SPK in a cell-type-specific manner, and suggest that cAMP suppression of apoptosis in RP-11 periosteal cells is mediated by its stimulation of SPK.
Assuntos
Apoptose/efeitos dos fármacos , Colforsina/farmacologia , AMP Cíclico/metabolismo , Periósteo/enzimologia , Fosfotransferases (Aceptor do Grupo Álcool)/metabolismo , Animais , Proteínas Quinases Dependentes de Cálcio-Calmodulina/efeitos dos fármacos , Contagem de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas/efeitos dos fármacos , Ativação Enzimática , Periósteo/citologia , Periósteo/metabolismo , Fosfotransferases (Aceptor do Grupo Álcool)/efeitos dos fármacos , Ratos , Ratos Sprague-DawleyRESUMO
Matrix metalloproteinases (MMPs), among which is collagenase (MMP-1), are likely to be involved in various steps of the bone resorption process. As both production of these enzymes and bone resorption appear to be mediated by cytokines, we investigated the effects of two cytokines, IL-1 alpha and EGF, on the release of collagenase, gelatinase A (MMP-2), gelatinase B (MMP-9), TIMP-1 and calcium by rabbit calvariae. It was found that all these parameters increased under the influence of these cytokines. The release of calcium--used as a parameter of bone resorption--was highest in the combined presence of the cytokines. Although the absolute and relative enhancement by a combination of IL-1 alpha and EGF was most pronounced for collagenase (7-fold), both gelatinase A (5-fold) and gelatinase B (1.5-fold) had increased simultaneously. Calvariae produced a high level of MMP inhibitor (TIMP-1), especially under the influence of the cytokines; periosteum released little inhibitor. It is concluded that IL-1 alpha and EGF are likely to play a modulating role in the process of bone resorption.
Assuntos
Cálcio/metabolismo , Colagenases/metabolismo , Fator de Crescimento Epidérmico/farmacologia , Gelatinases/metabolismo , Interleucina-1/farmacologia , Inibidores de Proteases/metabolismo , Crânio/metabolismo , Inibidor Tecidual de Metaloproteinase-1/metabolismo , Análise de Variância , Animais , Reabsorção Óssea/enzimologia , Reabsorção Óssea/metabolismo , Colagenases/efeitos dos fármacos , Técnicas de Cultura , Ensaio de Imunoadsorção Enzimática , Gelatinases/efeitos dos fármacos , Metaloproteinase 2 da Matriz , Metaloproteinase 9 da Matriz , Metaloendopeptidases/efeitos dos fármacos , Metaloendopeptidases/metabolismo , Periósteo/efeitos dos fármacos , Periósteo/enzimologia , Periósteo/metabolismo , Coelhos , Compostos Radiofarmacêuticos , Crânio/efeitos dos fármacos , Crânio/enzimologia , Timidina/metabolismo , Inibidor Tecidual de Metaloproteinase-1/efeitos dos fármacos , TrítioRESUMO
Demineralized bone matrix (DBM) is widely used in the repair of pathologies associated with skeletal defects and periodontal diseases. The present study was directed at establishing in vivo and in vitro models for a quantitative assessment of the osteoinductivity of DBM before clinical use. Athymic mice were used in an in vivo assay to overcome the species limitations (for human DBM) found in xenogeneic animal models. Calcium contents of explants, as an indicator of new bone formation, were assayed and expressed as a change in the weight percent calcium in the explant as compared to the weight percent of calcium in the implanted material. A total of 82 mice (2 implants per mouse) were used in this study. Significant amounts of new bone were induced in this animal model in response to implantation of DBM. Muscular implantation was found to be more osteoinductive (increases of 10.0 +/- 0.4 calcium weight percent of explant) than subcutaneous implantation (increases of 1.62 +/- 0.27 calcium weight percent of explant) and new bone formation in muscular implantation sites of athymic mice mimics endochondral bone formation. Between weeks 1 to 4, the weight of explanted materials did not significantly differ from the weight of the implanted material; however, by week 5 the explant weight began to increase. Calcium deposition over the 5 weeks of implantation increased in a nearly linear fashion. Consequently week 4 was chosen as the optimum time for explantation in the in vivo assay in that sufficient calcium levels had been achieved without a significant increase in explant dry weight. Aliquots of 10, 20, 30, and 40 mg per implantation site were used in dose response studies in the in vivo bioassay. Dose response curves with DBM exhibited maximal activity at the 20 mg DBM implant dose in the in vivo bioassay. An in vitro bioassay was also developed where human periosteal (HPO) cells were chosen because osteoprogenitor cells found in bone repair typically come from periosteal tissue. Alkaline phosphatase (ALP) activity in confluent cell cultures of HPO cells exposed to DBM, as an indicator of osteoblast induction, reached its highest level on day 5 of DBM treatment. Aliquots of 2, 5, 10, 20, 30, and 40 mg DBM per flask were chosen in dose response studies using the in vitro bioassay. These dose response studies with DBM revealed that quantities approximating 5 to 10 mg DBM in the in vitro model provided for maximal levels of ALP in cell extracts. A linear correlation (R2 = 0.7397) was demonstrated between the in vivo calcium remineralization assay and the in vitro ALP assay of osteoinductivity of DBM, suggesting that the in vitro assay can be used to quantitatively assess the osteoinductive potential of DBM where production and distribution of clinically usable DBM dictates rapid analysis.
Assuntos
Matriz Óssea , Substitutos Ósseos/uso terapêutico , Osteogênese , Adulto , Fosfatase Alcalina/metabolismo , Animais , Doenças Ósseas/cirurgia , Regeneração Óssea , Substitutos Ósseos/administração & dosagem , Substitutos Ósseos/análise , Calcificação Fisiológica , Cálcio/análise , Células Cultivadas , Tecido Conjuntivo/cirurgia , Técnica de Descalcificação , Procedimentos Cirúrgicos Dermatológicos , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Humanos , Masculino , Camundongos , Camundongos Nus , Músculo Esquelético/cirurgia , Osteoblastos/efeitos dos fármacos , Osteoblastos/enzimologia , Osteoblastos/fisiologia , Doenças Periodontais/cirurgia , Periósteo/efeitos dos fármacos , Periósteo/enzimologia , Periósteo/fisiologia , Fatores de Tempo , Transplante HeterólogoRESUMO
The relationships between residual calcium levels and particle size of ground demineralized bone matrix and its osteoinductive potential were investigated using in vitro and in vivo assays. The effects of variable residual calcium levels, variable particle sizes, and donor age and gender were studied using a tissue culture-based bioassay (in vitro) as well as an athymic mouse (in vivo) bioassay. The osteoinductive potential of the bone-derived biomaterial was assessed by measuring the degree of new bone formation (change in percent calcium content after 4 weeks of implantation) in the in vivo assay and levels of alkaline phosphatase activity associated with cultures of human periosteal cells (HPO cells) in the in vitro assay, respectively. Slightly demineralized bone matrix and overly demineralized bone matrix possessed a degree of osteoinductive potential whereas bone demineralized to levels of approximately 2% residual calcium provided for maximum osteoinductive potential in both assay systems. The osteoinductive potential of ground demineralized bone varied relative to the particle size such that DBM particles ranging from 500 to 710 microns provided for the highest level of calcium deposition (increase of 8.1 weight percent calcium) after 4 weeks of implantation in muscle pouches of an athymic mouse, whereas explanted particles less than 250 microns showed the lowest level of calcium deposition (increase of only 2.8 weight percent calcium). In the donor age and gender study, DBM from different donors were divided into 5 age groups for both female and male donor derived bone: less than 20, 21 to 30, 31 to 40, 41 to 50, and 51 to 60 year old age groups. This study indicated that DBM from female donors in the 31 to 40 years old age group and male donors in the 41 to 50 year age group possess the highest osteoinductive potential, whereas DBM derived from donor bone from both female and male donors in the 51 to 60 year age group presented the lowest osteoinductive potential. DBM derived from male and female donors did not in general show significant differences in osteoinductive potential.
Assuntos
Matriz Óssea , Substitutos Ósseos/uso terapêutico , Técnica de Descalcificação , Osteogênese , Adulto , Fatores Etários , Fosfatase Alcalina/análise , Fosfatase Alcalina/metabolismo , Animais , Materiais Biocompatíveis/análise , Materiais Biocompatíveis/química , Materiais Biocompatíveis/uso terapêutico , Bioensaio , Substitutos Ósseos/análise , Substitutos Ósseos/química , Cálcio/análise , Células Cultivadas , Técnicas de Cultura , Feminino , Humanos , Masculino , Camundongos , Camundongos Nus , Pessoa de Meia-Idade , Músculo Esquelético/cirurgia , Tamanho da Partícula , Periósteo/enzimologia , Fatores SexuaisRESUMO
Numerous data strongly suggest the involvement of cytokines and the matrix metalloproteinase collagenase (MMP-1) in the pathogenesis of periodontitis. Recently, we have demonstrated that, upon culturing under the influence of IL-1 alpha + EGF, a large amount of inactive procollagenase (MMP-1) is stored in the extracellular matrix of periosteal tissue. We now show that this endogenous reservoir of proenzyme can be operative after activation with plasmin and is able to induce a rapid and almost complete breakdown of the collagenous extracellular matrix. The level of collagen degradation following activation showed a strong correlation with the amount of proenzyme that was incorporated in the tissue. The highest level of degradation (70% of the total amount of collagenous proteins) was found with the IL-1 alpha + EGF-treated explants, followed by those treated with IL-1 alpha alone (35%). Explants cultured with EGF or in the absence of cytokines, containing only small amounts of procollagenase, showed little collagen breakdown following plasmin activation (7%). Inhibition of metalloproteinases by EDTA, or blockage of plasmin by PMSF, prevented the degradation in all explants irrespective of the amount of proenzyme present in the tissue. Our findings demonstrate that endogenous proenzyme stored in a native connective tissue matrix can be activated at a later time interval which results in a massive breakdown of the tissue. This study shows a possible pathway of collagenase-induced breakdown without recent de novo synthesis of the enzyme. Such a sequence may be operative in chronic inflammatory diseases, such as periodontitis, where production of procollagenase under the influence of cytokines spans a longer time period, whereas breakdown is often characterized by a cyclic behaviour.